4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow Malignant Neoplasm of Breast: new trials by email Literature Review of Malignant Neoplasm of Breast trials Research Report on Malignant Neoplasm of Breast
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA) Imprime PGG, Pembrolizumab - Malignant Neoplasm of Breast | Phase 2 | Completed | HiberCell, Inc. | 26 | 2021-11-09 | 2023-06-22 |
| Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC Pembrolizumab, nab-paclitaxel, Epirubicin - Malignant Neoplasm of Breast | Phase 2 | Completed | Institut fuer Frauengesundheit | 53 | 2018-03-23 | 2021-04-08 |
| Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer Paclitaxel, Alisertib - Breast Cancer, Breast Carcinoma | Phase 2 | Completed | US Oncology Research | 169 | 2015-02-12 | 2024-10-09 |
| Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer Genomically Directed Monotherapy, Observation/Standard Therapy - Malignant Neoplasm of Breast, Breast Cancer | Phase 2 | Completed | Bryan Schneider, MD | 193 | 2014-04-03 | 2023-09-28 |
Breast Neoplasms (4) · Triple Negative Breast Neoplasms (2)
Breast Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Skin Diseases (4) · Skin and Connective Tissue Diseases (4)
Albumin-Bound Paclitaxel (2) · Paclitaxel (2) · pembrolizumab (2) · 130-nm albumin-bound paclitaxel (1) · BTH1677 (1) · Cyclophosphamide (1) · Epirubicin (1) · MLN 8237 (1) · Observation (1) · Standard of Care (1)
Bryan Schneider, MD (1) · HiberCell, Inc. (1) · Institut fuer Frauengesundheit (1) · US Oncology Research (1)
United States (3) · Germany (1)
Alison Stopeck, MD (1) · Bryan Schneider, M.D. (1) · Joyce A. O'Shaughnessy, MD (1) · Peter A Fasching, MD, Prof. (1)
PMID 32644110, PMID 33877311, PMID 34910554, PMID 38745646
2016 (1)